Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Purple Biotech (PPBT) Assets Average (2016 - 2025)

Purple Biotech has reported Assets Average over the past 6 years, most recently at $56.6 million for Q4 2022.

  • Quarterly Assets Average fell 21.32% to $56.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $56.6 million through Dec 2022, down 21.32% year-over-year, with the annual reading at $62.4 million for FY2022, 18.95% down from the prior year.
  • Assets Average was $56.6 million for Q4 2022 at Purple Biotech, down from $60.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $84.8 million in Q4 2020 and troughed at $16.0 million in Q4 2019.
  • The 5-year median for Assets Average is $62.1 million (2022), against an average of $54.1 million.
  • Year-over-year, Assets Average surged 431.47% in 2020 and then fell 21.32% in 2022.
  • A 5-year view of Assets Average shows it stood at $16.5 million in 2018, then dropped by 3.6% to $16.0 million in 2019, then surged by 431.47% to $84.8 million in 2020, then fell by 15.19% to $71.9 million in 2021, then dropped by 21.32% to $56.6 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Assets Average are $56.6 million (Q4 2022), $60.1 million (Q3 2022), and $64.0 million (Q2 2022).